SPONSOR
Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 3, Phase 1
Conditions studied: Acute Coronary SyndromeSecondary Hyperparathyroidism, Chronic Kidney DiseaseHemodialysis Subjects With Secondary Hyperparathyroidism
Shaanxi Micot Pharmaceutical Technology Co., Ltd. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Acute Coronary Syndrome, Secondary Hyperparathyroidism, Chronic Kidney Disease, Hemodialysis Subjects With Secondary Hyperparathyroidism.
The trial portfolio spans Phase 2, Phase 3, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shaanxi Micot Pharmaceutical Technology Co., Ltd.
How many clinical trials has Shaanxi Micot Pharmaceutical Technology Co., Ltd. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Shaanxi Micot Pharmaceutical Technology Co., Ltd., of which 3 are actively recruiting participants. These trials cover conditions including Acute Coronary Syndrome, Secondary Hyperparathyroidism, Chronic Kidney Disease, Hemodialysis Subjects With Secondary Hyperparathyroidism. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shaanxi Micot Pharmaceutical Technology Co., Ltd. research focus on?
Shaanxi Micot Pharmaceutical Technology Co., Ltd. clinical trials span Acute Coronary Syndrome, Secondary Hyperparathyroidism, Chronic Kidney Disease, Hemodialysis Subjects With Secondary Hyperparathyroidism. The research pipeline includes Phase 2, Phase 3, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shaanxi Micot Pharmaceutical Technology Co., Ltd. clinical trial?
To participate in a Shaanxi Micot Pharmaceutical Technology Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shaanxi Micot Pharmaceutical Technology Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Shaanxi Micot Pharmaceutical Technology Co., Ltd.
NCT06533358 Phase 2
Recruiting
A Clinical Study of MT1002 in Subjects With Acute Coronary Syndrome Undergoing PCI
Acute Coronary Syndrome
NCT07122401 Phase 3
Recruiting
Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism
Secondary Hyperparathyroidism, Chronic Kidney Disease
NCT07284043 Phase 1
Recruiting
A Mass Balance Study of [14C] MT1013 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Hemodialysis Subjects With Secondary Hyperparathyroidism
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology